Japan, Feb. 6 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'METHODS FOR ENHANCING EFFICACY OF VACCINE BY ADMINISTERING IL-4R ANTAGONIST.' Other related details are as follows:

Application Number: JP,2022-152120

Category (FI): A61P37/08,C07K16/28,C12N15/13,A61K39/395@N,A61K39/00@G,A61P17/00,A61P37/04,A61K39/395@D,A61K39/39

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Sept. 26, 2022

Publication Date: Dec. 13, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....